Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06363253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Study of the Human Metagenome in Metabolic Diseases

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This is a cohort study to understand the role of the human metagenome, and associated metabolites, in health and in various diseased states, in particular obesity as well as sarcopenia. Recruited participants will have their fecal, salivary, urine, serum, and in certain instances, mucosal samples taken, for metagenomic sequencing and metabolite testing. We hope to uncover various differences and signatures in the metagenome and metabolome in various diseased states, with potential future therapeutic applications in personalised medicine.
Trial Details
NCT Number NCT06363253
Lead Sponsor Sengkang General Hospital
Collaborators: Singapore General Hospital, Nanyang Technological University, Duke-NUS Graduate Medical School
Conditions
(from sponsor)		 Obesity, Sarcopenia, Sarcopenic Obesity, Chronic Inflammation, Metabolic Syndrome
Related terms Metabolic Syndrome, Obesity, Sarcopenia
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov